Product Program year 2025 Source: CMS Open Payments

Coblation

Device Ent

PDI 00817470003888

Open in the dashboard

General payments

$230,844

230 payments

Research payments

$0

0 payments

Through program year 2025, $230,844 in general payments and $0 in research payments were reported against Coblation (Ent).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $108,423 90
2024 General $81,577 57
2023 General $7,690 32
2022 General $33,155 51

Breakdown

Who paid General payments · program years 2022–2025
  1. Smith+Nephew, Inc. $230,844 230 payments
Top recipients General payments · program year 2025
  1. Joshua Greene Otolaryngology · Anderson, IN $29,591 27% · 8 payments
  2. Kelvin Kwong Pediatric Otolaryngology · New Brunswick, NJ $23,066 21% · 18 payments
  3. Elisa Illing Otolaryngology · Indianapolis, IN $10,656 10% · 1 payment
  4. Zorik Spektor Pediatric Otolaryngology · Boynton Beach, FL $10,563 10% · 3 payments
  5. Jordan Schramm Pediatric Otolaryngology · Provo, UT $10,381 10% · 1 payment

The top 5 of 58 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatric Otolaryngology Otolaryngology $60,397 56% · 8 practitioners
  2. Otolaryngology $47,117 43% · 35 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $254 <1% · 3 practitioners
  4. Facial Plastic Surgery Otolaryngology $139 <1% · 3 practitioners
  5. Otology & Neurotology Otolaryngology $106 <1% · 2 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Indiana $40,294 37% · 4 recipients
  2. New Jersey $32,104 30% · 2 recipients
  3. Florida $10,563 10% · 1 recipient
  4. Utah $10,381 10% · 1 recipient
  5. Tennessee $5,008 5% · 1 recipient

The top 5 of 17 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

230 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record